|
|||
|
Sep. 16, 2024 Agri-Pulse reports: Bayer got a favorable verdict late last week when a Philadelphia Court of Common Pleas jury found that a Pennsylvania man's cancer did not result from his use of Roundup. "The jury's verdict in favor of the Company marks the 14th favorable outcome in the last 20 trials and validates the company's strategy of taking cases to trial based on strong scientific and regulatory evidence," Bayer said in a statement. The attorney for plaintiff Ryan Young told the Philadelphia Inquirer he was disappointed in the verdict but noted that the jury "did send a message to Monsanto that Roundup is defective." Bayer also said it was actively working to apply a federal 3rd Circuit Court of Appeals ruling to other Roundup cases "and looks forward to presenting its arguments, as fully embraced by the Third Circuit, at trial courts, appellate courts, and the U.S. Supreme Court." To read more about the decision click here. Tweet |
|
|
||||||||||||||||